Posts

Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs?

Authors: Jürg Gertsch
Journal of Leukocyte Biology, April 2016

Discussion of cannabinoid receptors and the ECS in macrophage activation.

Molecular Targets of Cannabidiol in Neurological Disorders.

Authors: Clementino Ibeas Bih, Tong Chen, Alistair V. W. Nunn, Michaël Bazelot, et al
Neurotherapeutics, October 2015

Cannabis has a long history of anecdotal medicinal use and limited licensed medicinal use. Until recently, alleged clinical effects from anecdotal reports and the use of licensed cannabinoid medicines are most likely mediated by tetrahydrocannabinol by virtue of: 1) this canna…

Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease.

Authors: Natalia Battista, Antonio Di Sabatino, Monia Di Tommaso, Paolo Biancheri, Cinzia Rapino, et al
PLoS One, 19 April 2013

Anandamide (AEA) is the prominent member of the endocannabinoid family and its biological action is mediated through the binding to both type-1 (CB1) and type-2 (CB2) cannabinoid receptors (CBR). The presence of AEA and CBR in the gastrointestinal tract highlighted their patho…